• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND VALIANT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND VALIANT; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number VAMF3838C200TU
Device Problem Inaccurate Delivery (2339)
Patient Problems Perforation of Vessels (2135); Vascular Dissection (3160)
Event Date 01/09/2014
Event Type  Injury  
Event Description
A valiant captivia stent graft system was implanted for the endovascular treatment of a 290 mm descending dissection in zone two.The maximum aneurysm diameter was 37.4 mm.The diameter from the caudal to the left carotid artery measured 36 mm.The diameter from the caudal to te left subclavian artery measuring 35.4 mm.It was reported that 37 days post implant, the patient presented to the emergency room with pain.It was discovered that the patient had a type a retrograde dissection so, the physician decided to do an open repair.A cortex graft was sewn into the existing stent graft.The physician stated the cause of the event was due to the bare springs had perforated the aorta in several locations.The physician decided to clip off the proximal portion of the springs that had perforated the aorta.No clinical sequelae were reported and the patient is fine.Film review analysis: review of returned films pre-implant showed that the patient had a type b dissection extending from the bottom of the arch, distally down to just proximal to the celiac.Images during implant or post-implant showing the type a dissection were not provided, and the cause of the type a dissection could not be determined.
 
Manufacturer Narrative
(b)(4).Evaluation method/results/ conclusion: inherent risk of procedure (dissection, aortic perforation, removal of implant), other (unknown cause of event), unapproved use of device (pre-implant dissection) evaluation codes.
 
Manufacturer Narrative
Conclusion: pre-implant dissection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VALIANT
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC CARDIOVASCULAR
3576 unocal place
santa rosa CA 95403
Manufacturer Contact
ludmila voulfson
3576 unocal place
santa rosa, CA 95403
7075661229
MDR Report Key3604827
MDR Text Key16916168
Report Number2953200-2014-00168
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P100040
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/13/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/08/2015
Device Catalogue NumberVAMF3838C200TU
Device Lot NumberV04130985
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/13/2014
Initial Date FDA Received02/03/2014
Supplement Dates Manufacturer ReceivedNot provided
Supplement Dates FDA Received02/13/2014
Date Device Manufactured10/09/2013
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age00050 YR
-
-